View Older Stories View More Recent Stories

Mar 25, 2025 12:23PM NVO DEADLINE TODAY: ROSEN, LEADING INVESTOR COUNSEL, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important March 25 Deadline in Securities Class Action - NVO

Mar 25, 2025 10:48AM INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk

Mar 25, 2025 09:06AM BMO Capital Reiterates Outperform Rating on Novo Nordisk (NVO)

Mar 24, 2025 04:00PM FINAL REMINDER NVO DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts Novo Nordisk A/S Investors to Participate in the Class Action Lawsuit!

Mar 24, 2025 12:18PM NVO DEADLINE TOMORROW: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important March 25 Deadline in Securities Class Action - NVO

Mar 24, 2025 08:04AM Novo Nordisk (NVO) expands Wegovy $499-per-month offering to additional cash-paying patients via the Wegovy savings offer

Mar 21, 2025 11:11PM NVO DEADLINE NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important March 25 Deadline in Securities Class Action - NVO

Mar 21, 2025 02:48PM NVO DEADLINE ALERT: Novo Nordisk (NVO) Investors with Losses Encouraged to Contact Hagens Berman Before Mar. 25th Deadline in Securities Class Action

Mar 20, 2025 11:06PM NVO DEADLINE ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Novo Nordisk A/S Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - NVO

Mar 19, 2025 11:01PM NVO DEADLINE ALERT: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Novo Nordisk A/S Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - NVO

Mar 18, 2025 08:23PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVO

Mar 17, 2025 08:18PM ROSEN, HIGHLY RECOGNIZED INVESTOR COUNSEL, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVO

Mar 17, 2025 02:19PM INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk

Mar 17, 2025 12:35PM NVO DEADLINE ALERT: Novo Nordisk (NVO) Investors with Losses Encouraged to Contact Hagens Berman Before Mar. 25th Deadline in Securities Class Action

Mar 16, 2025 06:41PM ROSEN, LEADING INVESTOR COUNSEL, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVO

Mar 15, 2025 06:41PM ROSEN, A TOP RANKED LAW FIRM, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVO

Mar 14, 2025 06:36PM ROSEN, LEADING INVESTOR COUNSEL, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVO

Mar 13, 2025 06:31PM NVO DEADLINE; ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVO

Mar 13, 2025 05:11AM Kepler Cheuvreux Upgrades Novo Nordisk (NOVOB:DC) (NVO) to Buy

Mar 12, 2025 03:10PM Novo Nordisk (NVO) Faces Securities Class Action After Weight Loss Therapy Trial Data Disappoints, Analyst Questions Trial's Design - Hagens Berman

Mar 11, 2025 09:23PM ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVO

Mar 10, 2025 04:52PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVO

Mar 10, 2025 02:02PM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk

Mar 10, 2025 06:59AM Novo Nordisk A/S (NVO): CagriSema demonstrates superior weight loss in adults with obesity or overweight and type 2 diabetes in the REDEFINE 2 trial

Mar 9, 2025 03:00PM ROSEN, A LEADING AND RANKED FIRM, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVO

Mar 9, 2025 08:10AM DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk

Mar 8, 2025 02:15PM ROSEN, SKILLED INVESTOR COUNSEL, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVO

Mar 6, 2025 07:59AM Bernstein Reiterates Market Perform on Novo Nordisk (NOVOB:DC) (NVO) Following NovoCare Pharmacy Launch

Mar 5, 2025 04:30PM ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVO

Mar 5, 2025 09:41AM Citi Reiterates Sell Rating on Hims and Hers (HIMS), PT $27, 'We view this as Novo taking a direct shot at HIMS'

Mar 5, 2025 09:26AM Amgen (AMGN) Starts Late-stage Studies Of Monthly Obesity Drug - Bloomberg, Citing Comments at Conf.

Mar 5, 2025 08:02AM Novo Nordisk (NVO) introduces NovoCare Pharmacy, lowering cost of all doses of FDA-approved Wegovy® (semaglutide) to $499 per month and offering easy home delivery for cash-paying patients

Mar 3, 2025 01:56PM ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVO

Mar 3, 2025 08:00AM These 5 stocks are latest additions to Goldman's 'European Conviction List - Directors’ Cut' list

Feb 28, 2025 12:56PM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk

Feb 27, 2025 01:00PM ROSEN, A LEADING LAW FIRM, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVO

Feb 26, 2025 06:42AM Bernstein Reiterates Market Perform Rating on Novo Nordisk (NOVOB:DC) (NVO)

Feb 25, 2025 03:15PM ROSEN, A LONGSTANDING LAW FIRM, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVO

Feb 24, 2025 06:17PM ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk

Feb 24, 2025 10:41AM TD Cowen Reiterates Buy Rating on Novo Nordisk (NVO) Following Management Meetings

Feb 22, 2025 04:00AM What's the current state of China's GLP-1 market?

Feb 21, 2025 01:43PM Novo Nordisk (NVO) Faces Securities Class Action After Weight Loss Therapy Trial Data Disappoints, Analyst Questions Trial's Design - Hagens Berman

Feb 21, 2025 11:41AM Analysts explain why Hims & Hers stock is crashing today

Feb 21, 2025 11:29AM Novo Nordisk (NVO) call put ratio 3.5 calls to 1 put with focus on February calls as share price up 5.5%

Feb 21, 2025 10:15AM ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk

Feb 21, 2025 09:18AM Novo Nordisk (NVO) Gains After FDA Says Ozempic Shortage Resolved

Feb 19, 2025 04:10PM ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVO

Feb 18, 2025 12:45PM ROSEN, A LEADING LAW FIRM, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVO

Feb 17, 2025 10:18AM DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk

Feb 16, 2025 11:16AM ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVO

View More Recent Stories View Older Stories